115 related articles for article (PubMed ID: 8855988)
1. 5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis.
du Bois A; Vach W; Wechsel U; Holy R; Schaefer W
Br J Cancer; 1996 Oct; 74(7):1137-40. PubMed ID: 8855988
[TBL] [Abstract][Full Text] [Related]
2. Urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion during multiple-day high-dose chemotherapy.
Janes RJ; Muhonen T; Karjalainen UP; Wiklund T
Eur J Cancer; 1998 Jan; 34(1):196-8. PubMed ID: 9624258
[TBL] [Abstract][Full Text] [Related]
3. The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens.
du Bois A; Vach W; Siebert C; Holy R; Ledergerber M; Wechsel U; Kriesinger-Schroeder H
Support Care Cancer; 1997 May; 5(3):212-8. PubMed ID: 9176967
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Higa GM; Auber ML; Altaha R; Piktel D; Kurian S; Hobbs G; Landreth K
J Oncol Pharm Pract; 2006 Dec; 12(4):201-9. PubMed ID: 17156592
[TBL] [Abstract][Full Text] [Related]
5. Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.
Alfieri AB; Cubeddu LX
Br J Cancer; 1995 Mar; 71(3):629-32. PubMed ID: 7533519
[TBL] [Abstract][Full Text] [Related]
6. Urinary serotonin metabolite excretion during cisplatin chemotherapy.
Wilder-Smith OH; Borgeat A; Chappuis P; Fathi M; Forni M
Cancer; 1993 Oct; 72(7):2239-41. PubMed ID: 7690681
[TBL] [Abstract][Full Text] [Related]
7. The role of serotonin as a mediator of emesis induced by different stimuli.
du Bois A; Kriesinger-Schroeder H; Meerpohl HG
Support Care Cancer; 1995 Sep; 3(5):285-90. PubMed ID: 8520873
[TBL] [Abstract][Full Text] [Related]
8. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.
Cubeddu LX; Hoffmann IS; Fuenmayor NT; Malave JJ
Br J Cancer; 1992 Jul; 66(1):198-203. PubMed ID: 1379060
[TBL] [Abstract][Full Text] [Related]
9. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion.
Fredrikson M; Hursti T; Fürst CJ; Steineck G; Börjeson S; Wikblom M; Peterson C
Br J Cancer; 1992 May; 65(5):779-80. PubMed ID: 1586608
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetic investigation of 5-day multiple dose of tropisetron capsule in patients who had received cisplatin and the usefulness of tropisetron capsule in the treatment of nausea and vomiting].
Suminaga M; Akasaka Y; Nukariya N; Kimura A; Ohtawa M
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1209-21. PubMed ID: 7544965
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting.
Higa GM; Auber ML; Hobbs G
Support Care Cancer; 2012 Nov; 20(11):2803-9. PubMed ID: 22350597
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.
du Bois A; Vach W; Holy R; Kriesinger-Schröder H
Support Care Cancer; 1996 Sep; 4(5):384-9. PubMed ID: 8883233
[TBL] [Abstract][Full Text] [Related]
13. Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
Cubeddu LX; O'Connor DT; Hoffmann I; Parmer RJ
Br J Cancer; 1995 Oct; 72(4):1033-8. PubMed ID: 7547218
[TBL] [Abstract][Full Text] [Related]
14. Effect of zatosetron on ipecac-induced emesis in dogs and healthy men.
Schwartz SM; Goldberg MJ; Gidda JS; Cerimele BJ
J Clin Pharmacol; 1994 Mar; 34(3):250-4. PubMed ID: 7517409
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F
J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.
Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL
N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807
[TBL] [Abstract][Full Text] [Related]
18. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.
Cubeddu LX; O'Connor DT; Parmer RJ
J Clin Oncol; 1995 Mar; 13(3):681-7. PubMed ID: 7533826
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced alterations of serotonin metabolism in patients with or without emesis following chemotherapy.
Dubois A; Siebert C; Vach W; Kriesingerschroeder H
Oncol Rep; 1995 Sep; 2(5):839-42. PubMed ID: 21597827
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis.
du Bois A; Vach W; Kiechle M; Cramer-Giraud U; Meerpohl HG
Oncology; 1996 Jun; 53 Suppl 1():46-50. PubMed ID: 8692551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
